Rehabilitation for Parkinson's (NCT06487364)
Rehabilitation measures meaningful daily improvements
- Trial ID
- NCT06487364
- Official Title
- Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8
- Goal
- Rehabilitation measures meaningful daily improvements
- Status
- RECRUITING
- Sponsor
- Emre Şenocak
- Study Type
- OBSERVATIONAL
- Enrollment
- 39 participants
- Conditions
- Parkinson Disease
- Interventions
- Rehabilitation
Summary For Families
The goal is to figure out how much change in the PDQ-8 quality of life score counts as a real, measurable difference and as a meaningful improvement for people with Parkinson's. Participants will take part in a rehabilitation program and complete the PDQ-8 before and after treatment, so researchers can calculate the minimal detectable change and the minimum clinically important change, with the PDQ-8 measuring Parkinson's-related daily life and wellbeing. The study is looking for people aged 40 to 80 with mild to moderate Parkinson's (Hoehn and Yahr stages 1,3), on stable Parkinson's medications with regular neurology follow-up, normal cognition (MMSE >24), and without other neurological disease, recent upper limb surgery or ongoing pain, active mood disorders, substance use, or uncorrectable vision or hearing loss.
Locations
- Private Güney Hospital, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Rehabilitation. The goal is to figure out how much change in the PDQ-8 quality of life score counts as a real, measurable difference and as a meaningful improvement for people with Parkinson's. Participants will take part in a rehabilitation program and complete the PDQ-8 before and after treatment, so researchers can calculate the minimal detectable change and the minimum clinically important change, with the PDQ-8 measuring Parkinson's-related daily life and wellbeing. The study is looking for people aged 40 to 80 with mild to moderate Parkinson's (Hoehn and Yahr stages 1,3), on stable Parkinson's medications with regular neurology follow-up, normal cognition (MMSE >24), and without other neurological disease, recent upper limb surgery or ongoing pain, active mood disorders, substance use, or uncorrectable vision or hearing loss.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 8 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- Evaluations are done at the beginning of the treatment program and at the end of the 30th session.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.